Bone Therapeutics
Biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.
Launch date
Employees
Market cap
$4.7m
Enterprise valuation
$22m (Public information from Nov 2022)
Share price
€0.1 BOTHE.BR
Charleroi Hainaut Province (HQ)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
Revenues | - | 1.0m | 13.0m | 21.0m |
% growth | - | - | 1200 % | 62 % |
EBITDA | (11.0m) | - | (22.0m) | 7.0m |
% EBITDA margin | - | - | (169 %) | 33 % |
Profit | (12.0m) | (14.0m) | (3.0m) | 4.0m |
% profit margin | - | (1400 %) | (23 %) | 19 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€7.7m | Series D | ||
N/A | €37.0m Valuation: €109m | IPO | |
* | N/A | €19.5m | Post IPO Equity |
€16.0m | Post IPO Debt | ||
* | N/A | €3.3m | Private Placement VC |
Total Funding | $12.1m |